Last update 17 Jan 2026

INR-101

Overview

Basic Info

Drug Type
Chemical drugs, Therapeutic radiopharmaceuticals
Synonyms
INR101
Target
PSMA
Action
modulators
Mechanism
PSMA modulators(Prostate-specific membrane antigen modulators)
Therapeutic Areas
NeoplasmsUrogenital Diseases
Active Indication
PSMA-Positive Prostatic CancerAdenocarcinoma of prostateRecurrent Prostate Carcinoma
Inactive Indication-
Originator Organization
Yun He Yi Yao （ Tian Jin ） You Xian Gong Si
Active Organization
Yun He Yi Yao （ Tian Jin ） You Xian Gong Si
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with INR-101
NCT06922903
/ Not yet recruitingPhase 3
A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate the Diagnostic Efficacy and Safety of INR101 Injection for PET/CT Imaging in Detecting Preoperative Pelvic Lymph Node Metastasis in Patients With Prostate Cancer
NCT06922929
/ Not yet recruitingPhase 3
A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate the Diagnostic Efficacy and Safety of INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment
NCT06472531
/ CompletedPhase 1/2
A Phase I/IIa Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer
100 Clinical Results associated with INR-101
Login to view more data
100 Translational Medicine associated with INR-101
Login to view more data
100 Patents (Medical) associated with INR-101
Login to view more data
1
Literatures (Medical) associated with INR-101
EJNMMI Research
Evaluation of INR101, a PSMA-Targeted 18F PET Tracer, for suspected prostate cancer: A multicenter phase I/IIa trial with histopathologic confirmation
100 Deals associated with INR-101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
PSMA-Positive Prostatic CancerPhase 3
China
Yun He Yi Yao （ Tian Jin ） You Xian Gong Si
29 Apr 2025
Adenocarcinoma of prostatePhase 3
China
Yun He Yi Yao （ Tian Jin ） You Xian Gong Si
01 Apr 2025
Recurrent Prostate CarcinomaPhase 3
China
Yun He Yi Yao （ Tian Jin ） You Xian Gong Si
01 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free